This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Movement Disorders  • Parkinson Disease/ Parkinsonian Disorders  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

A Systematic Review

Connie Marras, MD; Paula Rochon, MD,MPH; Anthony E. Lang, MD

Arch Neurol. 2002;59:1724-1728.

Context  The clinical course of Parkinson disease (PD) varies from patient to patient. A number of studies investigating predictors of prognosis in patients with PD have been performed.

Objective  To summarize evidence on predicting the rate of motor decline and increasing disability in early PD.

Data Sources  English-language and French-language literature cited in the MEDLINE database (1966-2002).

Study Selection  Cohort and case-control studies investigating associations between clinical features and subsequent motor impairment or disability were selected.

Data Extraction  Study methods and results were abstracted by a single reviewer.

Data Synthesis  The results of 13 studies were summarized qualitatively. Study methods were highly variable, particularly regarding the choice of outcome measure. Baseline motor impairment and cognitive impairment are probable predictors of more rapid motor decline and disability. A lack of tremor at onset and older age both appear to be predictive of increasing disability, but conflicting results exist for their association with the rate of change of motor impairment. Family history of PD does not appear to be prognostically important. The prognostic value of many other factors studied is uncertain owing to conflicting or unconfirmed results.

Conclusions  Uncertainty remains about the prognostic importance of many baseline clinical features in PD. Greater baseline impairment, early cognitive disturbance, older age, and lack of tremor at onset appear to be adverse prognostic factors.

From the Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University Health Network, University of Toronto (Drs Marras and Lang), the Kunin-Lunenfeld Applied Research Unit, Baycrest Center for Geriatric Care, University of Toronto (Dr Rochon), and the Institute for Clinical and Evaluative Sciences (Dr Rochon), Toronto, Ontario.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Course in Parkinson disease subtypes: A 39-year clinicopathologic study
Rajput et al.
Neurology 2009;73:206-212.
ABSTRACT | FULL TEXT  

Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype
Taylor et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:1318-1323.
ABSTRACT | FULL TEXT  

REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features
Postuma et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:1117-1121.
ABSTRACT | FULL TEXT  

Determinants of disability and quality of life in mild to moderate Parkinson disease
Muslimovic et al.
Neurology 2008;70:2241-2247.
ABSTRACT | FULL TEXT  

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
Schwarzschild et al.
Arch Neurol 2008;65:716-723.
ABSTRACT | FULL TEXT  

Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease
Bronnick et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:1064-1068.
ABSTRACT | FULL TEXT  

Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease
Bronnick et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1136-1142.
ABSTRACT | FULL TEXT  

Evaluation of the quality of prognosis studies in systematic reviews.
Hayden et al.
ANN INTERN MED 2006;144:427-437.
ABSTRACT | FULL TEXT  

Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials
Guimaraes et al.
Clin Trials 2005;2:509-518.
ABSTRACT  

Progression of motor impairment and disability in Parkinson disease: A population-based study
Alves et al.
Neurology 2005;65:1436-1441.
ABSTRACT | FULL TEXT  

Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up
Capecci et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:769-774.
ABSTRACT | FULL TEXT  

Progression of Parkinson Disease: Are We Making Progress in Charting the Course?
Jankovic
Arch Neurol 2005;62:351-352.
FULL TEXT  

Contribution of Aging to the Severity of Different Motor Signs in Parkinson Disease
Levy et al.
Arch Neurol 2005;62:467-472.
ABSTRACT | FULL TEXT  

Survival in Parkinson disease: Thirteen-year follow-up of the DATATOP cohort
Marras et al.
Neurology 2005;64:87-93.
ABSTRACT | FULL TEXT  

The Rate of Cognitive Decline in Parkinson Disease
Aarsland et al.
Arch Neurol 2004;61:1906-1911.
ABSTRACT | FULL TEXT